DEFA14A ·Filed Apr 16, 2026
Proxy solicitation materials
Actionable Insight • Neutral
This is a routine filing with no immediate trading implications. Monitor for any future filings that might indicate a more significant corporate action.
Final — all horizons settled through T+60d
VIR ▼ -5.91% at T+60d
NEUTRAL call ✗ call lost -5.91% · α vs SPY -12.95% · entry $10.33 → $9.72
T+1d
+4.07%
call +4.07% · α +2.85%
$10.75
settled 6mo ago
T+5d
+0.19%
call +0.19% · α -0.79%
$10.35
settled 5mo ago
T+20d
-9.68%
call -9.68% · α -15.50%
$9.33
settled 5mo ago
T+60d
-5.91%
call -5.91% · α -12.95%
$9.72
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Vir Biotechnology filed a definitive proxy statement (DEFA14A) following the recent departure of its Chief Medical Officer, Mark Eisner. The filing is routine and does not indicate any material changes or shareholder disputes.
Key Facts
- Filed a DEFA14A proxy statement
- Follows the recent departure of Chief Medical Officer Mark Eisner
- No activist campaign or shareholder dispute mentioned
- Filing is routine and procedural
Financial Impact
No material financial impact
Risk Factors
- Potential for future management changes
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001628280-26-025380 |
| Document: 0001628280-26-025380-index-headers.html | 0001628280-26-025380 |
| Document: 0001628280-26-025380-index.html | 0001628280-26-025380 |
| Document: 0001628280-26-025380.txt | 0001628280-26-025380 |
18 reports for VIR
40% Hit rate best @ T+60▲ +10.12%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 7w ago | Court Ruling | $9.24 $9.78 | ▲ +5.84% | ▲ +7.21% | $11.17 (+20.89%) |
Aug 9, 2026 7w ago | Institutional Cluster | $8.89 $9.39 | ▲ +5.62% | ▲ +5.67% | $11.17 (+25.65%) |
Jul 24, 2026 10w ago | 8-K | $8.69 $8.90 | ▲ +2.42% | ▲ +2.04% | $11.17 (+28.54%) |
Jun 29, 2026 13w ago | 144 | $10.38 $10.02 | ▼ −3.47% | ▼ −4.86% | $11.17 (+7.61%) |
Jun 10, 2026 16w ago | 3 | $8.52 $9.30 | ▲ +9.15% | ▲ +8.72% | $11.17 (+31.10%) |
Jun 10, 2026 16w ago | 8-K | $8.52 $9.30 | ▲ +9.15% | ▲ +8.72% | $11.17 (+31.10%) |
Jun 2, 2026 17w ago | Insider Cluster | $8.77 $8.25 | ▼ −5.93% | ▼ −2.11% | $11.17 (+27.37%) |
May 28, 2026 18w ago | 8-K | $9.55 $8.77 | ▼ −8.17% | ▼ −8.12% | $11.17 (+16.96%) |
Apr 16, 2026 24w ago | DEFA14A | $10.33 $10.35 | ▲ +0.19% | ▼ −0.79% | $11.17 (+8.13%) |
Apr 10, 2026 25w ago | 8-K | $9.31 $11.09 | ▲ +19.12% | ▲ +15.82% | $11.17 (+19.98%) |
Showing 10 of 18
US Market Status
Market Closed — Opens Mon (64h 9m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access